Mecamylamine Other names: 3-methylaminoisocamphane hydrochloride

Chemical formula: C₁₁H₂₁N  Molecular mass: 167.291 g/mol  PubChem compound: 4032

Active ingredient description

Mecamylamine (3-methylaminoisocamphane hydrochloride) is a nicotinic parasympathetic ganglionic blocker, originally utilized as a therapeutic agent to treat hypertension. Mecamylamine reduces blood pressure in both normotensive and hypertensive individuals.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
C02BB01 Mecamylamine C Cardiovascular system → C02 Antihypertensives → C02B Antiadrenergic agents, ganglion-blocking → C02BB Secondary and tertiary amines
Discover more medicines within C02BB01

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
VECAMYL Tablet FDA, National Drug Code (US) MPI, US: SPL/Old

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 60-40-2
DrugBank Drug: DB00657
PubChem Compound: 4032
RxNorm Ingredient: 6673
SNOMED-CT Concept: 372828008
Mecamylamine (substance)
UNII Identifier: 6EE945D3OK
MECAMYLAMINE

Medicines

Mecamylamine is an active ingredient of these brands:

United States (US)

  • VECAMYL as MECAMYLAMINE HYDROCHLORIDE

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.